LEUCOVORIN INCREASES THE TOXICITY OF 5-FLUOROURACIL - PHASE-I CLINICAL PHARMACOLOGICAL TRIALS

被引：0
|
作者：
BRUCKNER, HW [1 ]
STORCH, JA [1 ]
HOLLAND, JF [1 ]
机构：
[1] CUNY MT SINAI SCH MED,NEW YORK,NY 10029
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1981年 / 22卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：192 / 192
页数：1
相关论文
共 50 条
  • [11] RADIATION-THERAPY AND 5-FLUOROURACIL MODULATED BY LEUCOVORIN FOR ADENOCARCINOMA OF THE PANCREAS - A PHASE-I STUDY
    SCHIFELING, DJ
    KONSKI, AA
    HOWARD, JM
    DOBELBOWER, RR
    MERRICK, HW
    SKEEL, RT
    INTERNATIONAL JOURNAL OF PANCREATOLOGY, 1992, 12 (03) : 239 - 243
  • [12] LEUCOVORIN AS A CLINICAL POTENTIATOR OF 5-FLUOROURACIL TOXICITY AND ANTICANCER EFFICACY
    BRUCKNER, HW
    SPIGELMAN, M
    MOUNT SINAI JOURNAL OF MEDICINE, 1988, 55 (05): : 390 - 394
  • [13] PHASE-I CLINICAL AND PHARMACOLOGIC TRIAL OF TRIMETREXATE IN COMBINATION WITH 5-FLUOROURACIL
    HUDES, GR
    LACRETA, F
    DELAP, RJ
    GRILLOLOPEZ, AJ
    CATALANO, R
    COMIS, RL
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 24 (02) : 117 - 122
  • [14] PHASE-I STUDY OF PHOSPHONACETYL-L-ASPARTATE, 5-FLUOROURACIL, AND LEUCOVORIN IN PATIENTS WITH ADVANCED CANCER
    HAGEBOUTROS, A
    ROGATKO, A
    NEWMAN, EM
    MCALEER, C
    BRENNAN, J
    LACRETA, FP
    HUDES, GR
    OZOLS, RF
    ODWYER, PJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 35 (03) : 205 - 212
  • [15] A phase I study of sequential irinotecan and 5-fluorouracil/leucovorin
    Goldberg, RM
    Kaufmann, SH
    Atherton, P
    Sloan, JA
    Adjei, AA
    Pitot, HC
    Alberts, SR
    Rubin, J
    Miller, LL
    Erlichman, C
    ANNALS OF ONCOLOGY, 2002, 13 (10) : 1674 - 1680
  • [16] A PHASE-I STUDY OF CISPLATIN, 5-FLUOROURACIL AND LEUCOVORIN WITH ESCALATING DOSES OF HYDROXYUREA IN CHEMOTHERAPY NAIVE PATIENTS
    VOKES, EE
    RATAIN, MJ
    JANISCH, L
    HOFFMAN, PC
    GOLOMB, HM
    SCHILSKY, RL
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (02) : 217 - 218
  • [17] A phase I study of docetaxel, cisplatin, 5-fluorouracil and leucovorin
    Mulcahy, MF
    Loehrer, PJ
    Meropol, NJ
    Rademaker, AW
    Benson, AB
    ONCOLOGY, 2005, 68 (4-6) : 479 - 484
  • [18] PHASE-I AND PHARMACOLOGICAL STUDIES OF INTRA-PERITONEAL (IP) 5-FLUOROURACIL (5-FU)
    SPEYER, JL
    COLLINS, JM
    DEDRICK, RL
    BRENNAN, MF
    LONDER, H
    DEVITA, VT
    MYERS, CE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 352 - 352
  • [19] COMPARISON OF PHARMACOKINETICS OF 5-FLUOROURACIL AND 5-FLUOROURACIL WITH CONCURRENT THYMIDINE INFUSIONS IN A PHASE-I TRIAL
    KIRKWOOD, JM
    ENSMINGER, W
    ROSOWSKY, A
    PAPATHANASOPOULOS, N
    FREI, E
    CANCER RESEARCH, 1980, 40 (01) : 107 - 113
  • [20] PHASE-I STUDY OF 5-FLUOROURACIL AND LEUCOVORIN BY A 14-DAY CIRCADIAN INFUSION IN METASTATIC ADENOCARCINOMA PATIENTS
    BJARNASON, GA
    KERR, IG
    DOYLE, N
    MACDONALD, M
    SONE, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 33 (03) : 221 - 228
12345